MAY 29, 2014 9:00 AM PDT

Keynote Panel Discussion: Companion Diagnostics: Changing the Face of Healthcare, Doctors Hawkins, Joseph, and Frank

Speaker
  • Patrick Joseph, MD, Medical Director, Siemens Clinical Laboratory (SCL), Siemens Healthcare Diagnostics Richard Frank, MD, Chief Medical Officer, Clinical Strategy and Policy, Siemens Health
    Biography

       
      Dr. Richard Frank, MD 
       
      Dr. Richard Frank is Chief Medical Officer, Clinical Strategy and Policy, for Siemens Healthcare. With over 30 years global experience in the design, regulatory labeling, public and private payment for, and clinical adoption of therapeutic and diagnostic drugs and devices, Dr. Frank offers a broad, real-world perspective on the evolving role of diagnostics in todays healthcare marketplace. Dr. Franks similarly global experience with government agencies and non-governmental organizations (NGOs), and within both academia and industry, gives him particular expertise in clinical evidentiary standards, government policy, and the product-, market-, and delivery system-specific inefficiencies and issues that burden payers and delay or skew patients access to the benefits of innovation. 
       
      Dr. Patrick Joseph, MD
       
      Dr. Patrick Joseph serves as Medical Director for the Siemens Clinical Laboratory (SCL) of Siemens Healthcare Diagnostics in Berkeley, California. A distinguished infectious-disease specialist and epidemiologist, Dr. Joseph is an appointed Fellow of the Infectious Disease Society of America and the Society of Healthcare Epidemiologists of America. Dr. Joseph completed his specialty training in internal medicine, infectious disease, and laboratory medicine at the University of California, San Francisco, where he is currently Associate Clinical Professor of Medicine. Since 1983, he has practiced clinical medicine and held laboratory director roles for commercial and research laboratories that employ both conventional and novel molecular diagnostic techniques. He currently holds medical staff appointments with Highland Alameda County Medical Center, San Ramon Regional Medical Center, and Alta-Bates Summit Medical Center in Berkeley, California. 
       
       

    Abstract

    What is the future of personalized medicine? Featuring Dr. Trevor Hawkins (An Introduction to Companion Diagnostics), Dr. Patrick Joseph (Making It Personal for Patients), and Dr. Richard Frank (The Impact on Healthcare Policy), this lively panel discussion will highlight the many ways in which Companion Diagnostics are changing the face of healthcare.
    As a patient-centric shift continues to sweep our healthcare system, pharmaceutical companies are increasingly seeing the value of targeting treatments to specific patient populations, making their therapies more personal. In the burgeoning age of personalized medicine, companies are looking for ways to develop more specific, efficacious, and cost-effective treatments that are tailored to a patients needs, rather than focusing solely on the blockbuster drugs that have dominated the industry over the past few decades. Some companies have found novel ways to accommodate this shift, including adjusting their business models to focus on healthcare outcomes and collaborating with payers and providers to simplify reimbursement and provide tools and technologies to increase medication adherence.
    Join Drs. Hawkins, Joseph, and Frank and learn how companion diagnostics promises to change the way patients are treated, therapies may be prescribed, and tests are developed, and how this fast-moving evolution will impact all of healthcare.

    Learning Objectives:

    At the end of the presentation, attendees will be able to:

    • Understand how companion diagnostics may improve patient outcomes by personalizing medicine.
    • Appreciate the pathways for adoption and prescription of companion diagnostic tests.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources